Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Mucosal Barrier of the Stomach

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gut Microbiome and Metabolic and Immune Indices in Males with or without Evidence of Metabolic Dysregulation.

Journal of obesity & metabolic syndrome·2024

Same author

Assessment of a Multispecies Probiotic Supplement for Relief of Seasonal Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled Trial.

Journal of integrative and complementary medicine·2023

Same author

Australian Aboriginal Otitis-Prone Children Produce High-Quality Serum IgG to Putative Nontypeable <i>Haemophilus influenzae</i> Vaccine Antigens at Lower Titres Compared to Non-Aboriginal Children.

Frontiers in cellular and infection microbiology·2022

Same author

Predominant Bacterial and Viral Otopathogens Identified Within the Respiratory Tract and Middle Ear of Urban Australian Children Experiencing Otitis Media Are Diversely Distributed.

Frontiers in cellular and infection microbiology·2022

Same author

The impacts of faecal subsampling on microbial compositional profiling.

BMC research notes·2022

Same author

Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.

Immunity, inflammation and disease·2021

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Mucosal immunization: a realistic alternative.

Diana C Otczyk¹, Allan W Cripps

¹School of Medicine, Griffith Health, Griffith University, Queensland, Australia.

|December 15, 2010

Summary

This summary is machine-generated.

Mucosal immunization, targeting infection sites, offers advantages over traditional parenteral vaccines. Advances in delivery systems and understanding of mucosal immunity make it a promising vaccination strategy.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

Immunology
Vaccinology
Drug Delivery Systems

Background:

Most infections initiate at mucosal surfaces, yet parenteral vaccination is predominant.
Current parenteral vaccination strategies have limitations in conferring broad mucosal immunity.
Few vaccines are approved for mucosal administration due to delivery challenges.

Purpose of the Study:

To highlight the potential of mucosal immunization as an alternative vaccination strategy.
To discuss the advantages of mucosal vaccination in targeting infection sites.
To address the historical drawbacks and recent advancements in mucosal delivery systems.

Main Methods:

Review of current vaccination practices and their limitations.
Analysis of advances in mucosal delivery system technology.
Exploration of site-specific mucosal immune mechanisms.

Main Results:

Mucosal immunization offers a direct route to induce immunity at infection sites.
Recent technological progress has overcome previous limitations in mucosal delivery.
Improved understanding of mucosal immunity enhances the feasibility of this approach.

Conclusions:

Mucosal immunization presents a viable and advantageous alternative to parenteral vaccination.
Advancements in delivery systems are crucial for the successful implementation of mucosal vaccines.
Further research into mucosal immunity will optimize this promising vaccination strategy.